-
Kitsap Respiratory Illness Report: March 19 – March 25
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 12 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 3 positive influenza tests in the past week (1,710 cumulative (15.5% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (491 since the start of the … Kitsap Respiratory Illness Report: March 19 – March 25
-
Providers advised to vaccinate all children against HPV beginning at age nine
Advisory or Update, HIV & STDs, Immunization, Immunizations, News and Update, Prevention, Provider Resources, SchoolsHPV vaccines are safe and highly effective in preventing infection with cancer-causing strains of HPV. The American Cancer Society, the American Academy of Pediatrics, and the CDC Advisory Committee on Immunization Practices (ACIP), and now the Washington Department of Health recommend starting this vaccination series at age 9. The HPV vaccine is one of the … Providers advised to vaccinate all children against HPV beginning at age nine
-
Kitsap Respiratory Illness Report: March 19 – March 25
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 12 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 3 positive influenza tests in the past week (1,710 cumulative (15.5% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (491 since the start of the … Kitsap Respiratory Illness Report: March 19 – March 25
-
Providers advised to vaccinate all children against HPV beginning at age nine
Advisory or Update, HIV & STDs, Immunization, Immunizations, News and Update, Prevention, Provider Resources, SchoolsHPV vaccines are safe and highly effective in preventing infection with cancer-causing strains of HPV. The American Cancer Society, the American Academy of Pediatrics, and the CDC Advisory Committee on Immunization Practices (ACIP), and now the Washington Department of Health recommend starting this vaccination series at age 9. The HPV vaccine is one of the … Providers advised to vaccinate all children against HPV beginning at age nine
-
Health Advisory: COVID-19 Updates to Transferring Residents Between Long-Term Care and other Healthcare Settings
Advisory or Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, News and Alerts, News and Update, Novel CoronavirusActions Requested Be aware, Washington Department of Health updated the Interim Guidance for Transferring Residents between Long-Term Care and other Healthcare Settings to address health care system capacity shortages. The interim guidance, effective January 21, 2022 until February 18, 2022, waives guidance asking facilities to pause admissions with identified healthcare personnel or facility acquired COVID-19 … Health Advisory: COVID-19 Updates to Transferring Residents Between Long-Term Care and other Healthcare Settings
-
Kitsap Respiratory Illness Report January 9 – January 15, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.9.22 – 1.15.22.
-
Kitsap Respiratory Illness Report January 2 – January 8, 2022
Click here to access latest Kitsap Respiratory Illness Report: 1.2.22 – 1.8.22.
-
Health Advisory: CDC updated antiviral guidance
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Health Alert, Immunization, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, SchoolsActions Requested Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and should not be used … Health Advisory: CDC updated antiviral guidance
-
01/06/22 Health Advisory: Booster Eligibility Expanded
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens … 01/06/22 Health Advisory: Booster Eligibility Expanded
-
01/04/22 Health Advisory: CDC updated antiviral guidance
Advisory or Update, COVID-19, Health Advisory, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and … 01/04/22 Health Advisory: CDC updated antiviral guidance
-
Kitsap Respiratory Illness Report December 19 – December 25, 2021
Click here to access the latest Kitsap Respiratory Illness Report: 12.19.21 – 12.25.21.
-
Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir
COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Infection Control, News and AlertsActions Requested Be aware, Centers for Disease Control and Prevention (CDC) issued new isolation and quarantine (I&Q) guidance for healthcare workers (HCWs). The guidance is complex and varies based on vaccination status, level of exposure and level of crisis in the community. Carefully review the new guidance for details. Following exposure, CDC recommends: Boosted HCWs … Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir
-
Health Advisory: Paxlovid Granted EUA and Testing Before Gathering
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Immunization, Immunizations, Infection Control, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Prevention, Provider Resources, Schools, Travel, VaccineActions Requested Be aware, Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first oral antiviral treatment for COVID-19, Pfizer’s Paxlovid. The EUA comes after research showed Paxlovid was nearly 90% effective at preventing hospitalization and death in people 12 years or older at high risk of severe outcomes within 5 days … Health Advisory: Paxlovid Granted EUA and Testing Before Gathering
-
Health Advisory: Updated J&J Vaccine Recommendations
Requested actions Be aware, on December 16, Centers for Disease Control and Prevention (CDC) recommended mRNA COVID-19 vaccines (Pfizer or Moderna) over Johnson & Johnson (J&J) COVID-19 vaccine for all people 18 years or older. The recommendation is based on the increased risk of thrombosis with thrombocytopenia syndrome (TTS) after getting J&J COVID-19 vaccine. Be … Health Advisory: Updated J&J Vaccine Recommendations
-
Kitsap Respiratory Illness Report December 5 – December 11, 2021
Click here to access the latest Kitsap Respiratory Illness Report: 12.5.21 – 12.11.21.
